Hyperfine has tapped NVIDIA to improve its AI-driven portable MR technology, aiming to make brain imaging faster, more efficient, and widely accessible.

The partnership will focus on refining image reconstruction and integrating real-time clinical decision support into Hyperfine’s Swoop portable MR system.

The Guilford, Connecticut-based company developed Swoop as the first FDA-cleared portable MR system, designed to be used at the point of care by trained clinicians. According to the World Health Organization, neurological conditions affect over 3 billion people worldwide, yet 90% of the global population lacks timely access to MR diagnostics.
By leveraging NVIDIA’s AI tools, including DALI and MONAI, the collaboration aims to enhance Swoop’s image quality, reduce scan times, and improve diagnostic accuracy.

“Our mission is to make portable brain imaging faster, more intelligent, and increasingly accessible — ultimately improving health outcomes and reducing costs globally,” said Maria Sainz, president and CEO of Hyperfine. “Partnering with NVIDIA presents an incredible opportunity to advance and accelerate our AI technology.”

The Swoop system is FDA-cleared for brain imaging across all age groups and is also CE-marked in the European Union and UKCA-marked in the United Kingdom. It is commercially available in select international markets.

Artificial Intelligence Homepage